Becton Dickinson BDX
NYSE BDX
$179.76 +1.71 (+0.96%)
As of: Sep 9, 2026 · 3:59 PM EDT

Becton Dickinson (BDX) Non-Current Debt (2009 - 2026)

Becton Dickinson's (BDX) quarterly Non-Current Debt came in at $13.5 billion in Q2 2026, down 22.93% year-over-year from $17.5 billion in Q2 2025, and down 8.13% quarter-over-quarter from $14.7 billion in Q1 2026.

Analysis

Becton Dickinson (BDX) Non-Current Debt (2009 - 2026) Analysis & Trends

Becton Dickinson (BDX) has reported Non-Current Debt for 18 consecutive years, with $13.5 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Debt fell 22.93% year-over-year to $13.5 billion in Q2 2026; TTM through Jun 2026 was $13.5 billion, a 22.93% decrease from a year earlier, with the FY2025 full-year figure at $17.6 billion, down 1.78% from the prior year.
  • Non-Current Debt was $13.5 billion for Q2 2026 at Becton Dickinson, down from $14.7 billion in the prior quarter.
  • Over five years, Non-Current Debt peaked at $18.1 billion in Q2 2024 and troughed at $13.5 billion in Q2 2026.
  • A 5-year average of $16.0 billion and a median of $16.0 billion in 2023 frame the typical range for Non-Current Debt.
  • Across the five-year window, Non-Current Debt grew 23.74% in 2024 and slipped 22.93% in 2026, its largest moves.
  • Over 5 years, Non-Current Debt stood at $14.3 billion in 2022, then fell by 1.22% to $14.1 billion in 2023, then grew by 23.74% to $17.4 billion in 2024, then decreased by 3.0% to $16.9 billion in 2025, then slipped by 20.13% to $13.5 billion in 2026.
  • The last three Non-Current Debt figures came in at $13.5 billion (Q2 2026), $14.7 billion (Q1 2026), and $16.9 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Becton Dickinson 50.32 Bn 49.46 Bn 2.32 Bn 13.51 Bn
2 Medline 48.11 Bn 52.93 Bn 2.22 Bn 12.55 Bn
3 West Pharmaceutical Services 23.93 Bn 23.49 Bn 329.20 Mn 202.90 Mn
4 Baxter International 13.34 Bn 11.16 Bn 1.03 Bn 8.62 Bn
5 Stevanato Group S.p.A 6.21 Bn 6.11 Bn 100.91 Mn 370.86 Mn
6 Acme United 241.34 Mn 236.30 Mn 26.69 Mn 22.64 Mn
7 Rockwell Medical 31.74 Mn 6.94 Mn 3.24 Mn 7.24 Mn
8 Retractable Technologies 21.26 Mn -18.61 Mn 190,852.00 336,991.00
9 United Health Products 12.24 Mn 12.21 Mn - 80,924.00
10 Cuprina Holdings (Cayman) 8.09 Mn 4.97 Mn - 126,201.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.51 Bn
Mar 31, 2026 14.71 Bn
Dec 31, 2025 16.92 Bn
Sep 30, 2025 17.62 Bn
Jun 30, 2025 17.53 Bn
Mar 31, 2025 17.67 Bn
Dec 31, 2024 17.44 Bn
Sep 30, 2024 17.94 Bn
Jun 30, 2024 18.13 Bn
Mar 31, 2024 16.00 Bn
Dec 31, 2023 14.09 Bn
Sep 30, 2023 14.74 Bn
Jun 30, 2023 14.93 Bn
Mar 31, 2023 16.01 Bn
Dec 31, 2022 14.27 Bn
Sep 30, 2022 13.89 Bn
Jun 30, 2022 14.68 Bn
Mar 31, 2022 17.58 Bn
Dec 31, 2021 16.36 Bn
Sep 30, 2021 17.11 Bn